Researchers at Memorial Sloan Kettering Cancer Center identified a signaling molecule called MEK that drives T cell exhaustion by pushing the cells to burn through their energy during cancer immunotherapy. Published in Immunity, animal and laboratory studies showed that blocking MEK helped T cells c